Jan 28, 2008 WALTHAM, Mass.-Jan. 23, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that Robert F. Friel has been elected Chief Executive Officer by the Company's Board of Directors effective February 1, 2008. He will also retain the title of President.
Gregory L. Summe will continue in the role of Executive Chairman of the Board, and remain as such through the Annual Shareholders meeting in April 2009. Today's announcement is consistent with the Company's leadership succession plan announced in July 2007.
Friel joined PerkinElmer in 1999 as Chief Financial Officer, and was appointed Vice Chairman and President of its Life and Analytical Sciences business in 2006. In 2007, Friel was appointed President and Chief Operating Officer of the Company.
"I am honored by the Board's decision and look forward to leading PerkinElmer," said Friel. "The Company has a great set of businesses, outstanding employees and is well-positioned to continue to drive advancements in Health Sciences and Photonics. I look forward to building on the strong foundation to deliver sustainable growth."
"Rob has a long track record of results in a wide variety of challenging roles and knows the Company extremely well," said Summe. "The Board of Directors and I believe that Rob is the right leader to drive PerkinElmer's future growth and expansion, and look forward to his continued success."
PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company projects revenues of $1.8 billion in 2007, has 9,100 employees serving customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through http://www.perkinelmer.com or 1-877-PKI-NYSE.
.gif)
